The exponential growth in the use of Direct-to-Patient clinical trials and the strategies pharmaceutical manufacturers should consider when implementing this model.
Michael Sweeney
Advertisement
Articles by Michael Sweeney
Q&A explores the evolution of community-based studies-and the related sample management, regulatory, compliance, and logistics support considerations.
Advertisement
Latest Updated Articles
The Growth of Direct-to-Patient TrialsPublished: October 1st 2016 | Updated:
- Direct-to-Patient Clinical Trials: Strategies for Success
Published: November 29th 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
2025 SCRS Global Site Solutions Summit: How to Streamline Site Qualification and Initiation Training
4
AI in Action: Breaking Down Clinical Trial Bottlenecks
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
